Search
Search Results
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2009
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Forecasting
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2009
- Subject(s):
- Drug Costs -- statistics & numerical data
Health Expenditures -- statistics & numerical data
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- trends
Drugs, Generic -- economics
Forecasting
Health Expenditures -- trends
Inflation, Economic
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2011
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- statistics & numerical data
Forecasting
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2012
- Subject(s):
- Drug Costs -- trends
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- statistics & numerical data
Drugs, Generic -- economics
Forecasting
Pharmaceutical Preparations -- economics
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2010
- Subject(s):
- Drug Costs -- trends
Prescription Drugs -- economics
Drugs, Generic -- economics
Forecasting
Health Care Reform -- economics
Inflation, Economic
Medicare Part D -- economics
Pharmaceutical Preparations -- economics
Humans
United States
- Author(s):
- Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
- Subject(s):
- Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Biosimilar Pharmaceuticals -- economics
Cost Control -- legislation & jurisprudence
Drugs, Generic -- economics
Economics, Pharmaceutical
Financing, Personal
Fraud
Legislation, Drug
Medicare Part C
Opioid-Related Disorders
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
